US › Healthcare

Oncology Institute Inc (TOI)

US · Healthcare · Medical Care Facilities

$5.13+5.56%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$147.4M
Revenue YoY
+41.2%
Net profit
$-2.5M
Profit YoY
+87.3%
EPS
$-0.02
EPS estimate
$-0.09
Net margin
-1.7%

EPS came in at -0.02 against a street estimate of -0.09 — a beat of 77.8%.

Key statistics

Market cap
$485.9M
Forward P/E
0.0
P/B
0.76
Book value
$-0.16
EPS (TTM)
$-0.35
52-week high
$6.67
52-week low
$2.32
50-day MA
$5.14
200-day MA
$3.85
Beta
0.39

Analyst view

Analysts rate Oncology Institute Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $8.40.

Shareholding

Insiders
18.28%
Institutions
45.57%

Largest institutional holders

FundStake
BlackRock Inc4.42%
Vanguard Capital Management, LLC3.48%
Deerfield Management Co3.36%
Kanen Wealth Management LLC2.78%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC2.46%
Balyasny Asset Management LLC1.83%
Geode Capital Management, LLC1.76%
Wexford Capital LP1.71%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Oncology Institute Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.